UroGen Pharma Ltd. short interest in 2025

In 2025, UroGen Pharma Ltd.'s disclosed short interest ran from 14.20% of shares outstanding on 15 Jan 2025 to 20.38% on 31 Dec 2025, a change of +6.18 percentage points. The year's high was 24.11% on 31 Oct 2025 and its low 8.49% on 30 May 2025, averaging 15.55% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.65 days on 31 Jan 2025. Full history: UroGen Pharma Ltd..

Cite this page

Plain

Short position data for UroGen Pharma Ltd. short interest in 2025: FINRA, compiled by howshorted.com, settlement date 31 Dec 2025. https://howshorted.com/us/company/urgn/2025/

Wikipedia

<ref>{{cite web |title=UroGen Pharma Ltd. short interest in 2025 short position data |url=https://howshorted.com/us/company/urgn/2025/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2025-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-urogen-pharma-ltd-short-interest-in-2025-2025-12-31,
  title        = {UroGen Pharma Ltd. short interest in 2025 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/urgn/2025/}},
  note         = {Data: FINRA, settlement date 31 Dec 2025; accessed 2026-10-13},
  year         = {2025}
}

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2025 in figures

Start of year: 14.20% (15 Jan 2025)
End of year: 20.38% (31 Dec 2025)
Change: +6.18 pp
High: 24.11% (31 Oct 2025)
Low: 8.49% (30 May 2025)
Average: 15.55%
Highest days to cover: 24.65 (31 Jan 2025)
SEC filings marked: 8

Every report in 2025

UroGen Pharma Ltd. short interest in 2025
Settlement	Short interest	Days to cover	Filings since previous
15 Jan 2025	14.20%	12.11
31 Jan 2025	14.59%	24.65
14 Feb 2025	14.67%	18.94
28 Feb 2025	14.50%	15.58
14 Mar 2025	14.57%	14.86	10-K filed, results (8-K)
31 Mar 2025	13.39%	13.32
15 Apr 2025	11.99%	9.93
30 Apr 2025	10.88%	6.38
15 May 2025	12.12%	8.16	10-Q filed, results (8-K)
30 May 2025	8.49%	1.00
13 Jun 2025	13.28%	1.00
30 Jun 2025	11.83%	1.65
15 Jul 2025	15.82%	6.79
31 Jul 2025	15.49%	4.95
15 Aug 2025	14.85%	5.93	10-Q filed, results (8-K)
29 Aug 2025	15.17%	7.42
15 Sep 2025	17.17%	5.89
30 Sep 2025	18.84%	7.32
15 Oct 2025	24.10%	9.95
31 Oct 2025	24.11%	13.57
14 Nov 2025	19.18%	5.34	10-Q filed, results (8-K)
28 Nov 2025	16.98%	7.29
15 Dec 2025	16.53%	8.25
31 Dec 2025	20.38%	13.54

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.